GRCE (gracetx.com) Bozor qiymatining balans qiymatiga nisbati
Grace Therapeutics, Inc. (GRCE) laboratoriya inshootlari qat'iy tartibga solish tizimi ostida ishlaydi, bu esa ishlab chiqarish maydonlarining sinov partiyalarini chiqarishga to'liq tayyorligini ta'minlaydi. Biznes modeli noyob dorilar sintezi va klinik sinovlarni tashqi pudratchilarga to'liq autsorsing qilishga asoslangan bo'lib, bu kompaniyani hamkorlarning ishonchliligiga bog'liq qiladi. Joriy ko'rsatkich 0.67 ni tashkil qiladi. Narxlar harakatida aks ettirilgan bozor dinamikasi loyihalarning ilmiy ahamiyatidan kelib chiqqan holda ixtisoslashgan olimlar jamoasi bilan to'ldiriladi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_GRCE_-_Grace-Therapeutics-Inc._-_Capitalization-to-Book-Value-Ratio "GRCE Grace Tx Bozor kapitallashuvining balans qiymatiga nisbati (29.10.2024 - 29.10.2026) | 👁️GURU.Markets👁️")
Grace Therapeutics, Inc. (GRCE) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Grace Therapeutics, Inc.|GRCE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati gracetx.com|GRCE - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Grace Tx|GRCE - Uzoq muddatli qarzdorlik|Kompaniyaning qisqa muddatli qarzi Grace Therapeutics
Kompaniyaning dastlabki tahlili:Grace Therapeutics Inc GRCE
Bozor qiymatining kitob kapitalidan yuqori bo'lgan ushbu premium Grace Therapeutics, Inc. (GRCE) kompaniyasining yuqori xavfli biotexnologiya startapi sifatidagi maqomini xarakterlaydi. Ushbu metrika aktivlarning joriy bozor bahosini ularning kitob qiymati bilan solishtirib, investorlarning kelajakdagi muvaffaqiyatlarga bo'lgan kutganlarini aks ettiradi. Yuqori koeffitsient tijorat daromadlarining yo'qligi va klinik sinovlar natijalariga tayanilgan garovlar hisobiga shakllangan. Indikatorning markaziy bank stavkalariga sezgirligi tadqiqot dasturlari uchun kapital tannarxini belgilaydi. Joriy haddan ortiq baholanish faqatgina operatsion foydaga emas, balki intellektual salohiyatga asoslangan.
Toʻgʻridan-toʻgʻri raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati BIIB|NBIX (neurocrine.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Amylyx Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati TRVI|Praxis Precision Medicines, Inc. (PRAX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Anavex (AVXL)|Bozor kapitallashuvining balans qiymatiga nisbati CBLL (CeriBell Corp)|Bozor kapitallashuvining balans qiymatiga nisbati Prothena PRTA|ALEC: Bozor kapitallashuvining balans qiymatiga nisbati|ANNX - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati OMER|Bozor qiymatining balans qiymatiga koeffitsiyenti Neurogene Inc|ACIU - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Voyager Corp (VYGR)|Kapitallashuvning sof aktivlarga nisbati Neumora Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori scilexholding.com (SCLX)|Bozor kapitallashuvining balans qiymatiga nisbati Tevogen Bio|Balans qiymatiga nisbatan bozor qiymati Alpha Cognition Inc ACOG|CGTX (Cognition Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|IKT: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Cassava Sciences, Inc. SAVA|Assertio (ASRT) - Balans qiymatiga nisbatan bozor qiymati|COYA (Coya Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VTGN|OVID - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Acumen Pharmaceuticals, Inc (ABOS)|CRVO: Bozor kapitallashuvining balans qiymatiga nisbati|ATHE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Clene Nanomedicine - Kapitallashuvning sof aktivlarga nisbati|PepGen Inc. (PEPG) - Bozor kapitallashuvining balans qiymatiga nisbati|JUNS - Kapitallashuvning sof aktivlarga nisbati|Relmada Corp (RLMD) - Bozor kapitallashuvining balans qiymatiga multiplikatori|ANVS: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi fireflyneuro.com|Bozor kapitallashuvining balans qiymatiga nisbati KLTO (Klotho Neurosciences Inc)|Kapitallashuvning sof aktivlarga nisbati NRSN (neurosense-tx.com)|Bozor qiymatining balans qiymatiga nisbati RVPH|MTVA - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati NeurAxis, Inc. (NRXS)|HSDT - Balans qiymatiga nisbatan bozor qiymati|passagebio.com - Bozor kapitallashuvining balans qiymatiga nisbati|NEUP (Neuphoria Therapeutics) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Minerva Neurosciences Corp (NERV)|Kapitallashuvning balans qiymatiga nisbati Athira Pharma Corp|Bozor kapitallashuvining balans qiymatiga nisbati ADXN (Addex Therapeutics)|Kapitallashuvning sof aktivlarga nisbati alzamend.com ALZN|Kapitallashuvning sof aktivlarga nisbati CYCN|Balans qiymatiga nisbatan bozor kapitallashuvi Protagenic Therapeutics Inc. PTIX|Bozor kapitallashuvining balans qiymatiga nisbati KTTA|CRGT: Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Avenue Therapeutics ATXI|brainstorm-cell.com (BCLI) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CARA|Kapitallashuvning sof aktivlarga nisbati Chromocell Therapeutics Corp|Eliem Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ITCI (intracellulartherapies.com)|LBPH - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati marinuspharma.com MRNS|NKGN (NKGen Biotech) - Bozor kapitallashuvining balans qiymatiga nisbati|NeuroBo Pharmaceuticals Inc (NRBO) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SAGE: Kapitallashuvning sof aktivlarga nisbati|SNPX (Synaptogenix, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|TRVN - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati VIGL|Anew Medical, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Cerevel Therapeutics Inc (CERE)